Resorcylidene aminoguanidine (RAG) improves cardiac mitochondrial bioenergetics impaired by hyperglycaemia in a model of experimental diabetes

International Journal of Molecular Sciences

Volumn 12, Issue 11, 2011, Pages 8013-8026

  Labieniec Watala, Magdalena ^a   Siewiera, Karolina ^a   Jozwiak, Zofia ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Mitochondrial respiratory; Oxygraph oroboros; RAG ( resorcylidene aminoguanidine); Streptozotocin diabetes

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED PROTEIN; RESORCYLIDENE AMINOGUANIDINE; STREPTOZOCIN; UNCLASSIFIED DRUG; AMINOGUANIDINE; ENZYME INHIBITOR; GLUCOSE BLOOD LEVEL; GUANIDINE DERIVATIVE;

ADP/O RATIO; ANALYTICAL PARAMETERS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG EFFICACY; ELECTRON TRANSPORT; GLUCOSE BLOOD LEVEL; HEART MITOCHONDRION; HEART PROTECTION; HYPERGLYCEMIA; IN VIVO STUDY; ISOLATED HEART; LEAK CONTROL RATIO; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHOSPHORYLATION SYSTEM CONTROL RATIO; RAT; RESPIRATORY CONTROL RATIO; RESPIROMETRY; STREPTOZOCIN DIABETES; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; ENERGY METABOLISM; HEART; METABOLISM; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ELECTRON TRANSPORT; ENERGY METABOLISM; ENZYME INHIBITORS; GUANIDINES; HEART; HYPERGLYCEMIA; MALE; MITOCHONDRIA, HEART; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RATS; RATS, WISTAR;

EID: 82255172274     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12118013     Document Type: Article

References (17)

1. Rolo, A.P.; Palmeira, C.M. Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharm. 2006, 212, 167-178.
2. Oliveira, P.J.; Rolo, A.P.; Seica, R.; Santos, M.S.; Palmeira, C.M.; Moreno, A.J. Reduction in cardiac mitochondrial calcium loading capacity is observable during alpha-naphthylisothiocyanateinduced acute cholestasis: A clue for hepatic-derived cardiomyopathies? Biochim. Biophys. Acta 2003, 1637, 39-45.
3. Shen, G.X. Oxidative stress and diabetic cardiovascular disorders: Roles of mitochondria and NADPH oxidase. Can. J. Physiol. Pharmacol. 2010, 88, 241-248.
4. Ferreira, F.M.; Palmeira, C.M.; Seica, R.; Moreno, A.J.; Santos, M.S. Diabetes and mitochondrial bioenergetics: Alterations with age. J. Biochem. Mol. Toxicol. 2003, 17, 214-222.
5. Yagihashi, S.; Kamijo, M.; Baba, M.; Yagihashi, N.; Nagai, K. Effects of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 1992, 41, 47-52.
6. Thornalley, P.J. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys. 2003, 419, 31-40.
7. Liptakova, A.; Carsky, J.; Ulicna, O.; Vancova, O.; Bozek, P.; Durackova, Z. Influence of beta-resorcylidene aminoguanidine on selected metabolic parameters and antioxidant status of rats with diabetes mellitus. Physiol. Res. 2002, 51, 277-284.
8. Vojtassak, J.; Blasko, M.; Danisovic, L.; Carsky, J.; Durikova, M.; Repiska, V.; Waczulikova, I.; Bohmer D. In vitro evaluation of the cytotoxicity and genotoxicity of resorcylidene aminoguanidine in human diploid cells B-HNF-1. Folia Biol. (Praha) 2008, 54, 109-114.
9. The OROBOROS Oxygraph-2k-a new Quality in Science. Available online: http://www.oroboros.at/ (accessed on 15 November 2011).
10. Ferko, M.; Habodaszova, D.; Waczulikova, I.; Mujkosova, J.; Kucharska, J.; Sikurova, L.; Ziegelhoffer, B.; Styk, J.; Ziegelhoffer, A. Endogenous protective mechanisms in remodeling of rat heart mitochondrial membranes in the acute phase of streptozotocin-induced diabetes. Physiol. Res. 2008, 57, S67-S73.
11. Lumini-Oliveira, J.; Magalhaes, J.; Pereira, C.V.; Moreira, A.C.; Oliveira, P.J.; Ascensao. A. Endurance training reverts heart mitochondrial dysfunction, permeability transition and apoptotic signaling in long-term severe hyperglycemia. Mitochondrion 2011, 11, 54-63.
12. 2+-ATPase activity, content of conjugated dienes and membrane fluidity. Physiol. Res. 2008, 57, S75-S82.
13. 2+ overload. J. Physiol. Pharmacol. 2002, 53, 727-739.
14. Ziegelhoffer, A.; Ravingerova, T.; Styk, J.; Sebokova, J.; Waczulikova, I.; Breier, A.; Dzurba, A.; Volkovova, K.; Carsky, J.; Turecky, L. Mechanisms that may be involved in calcium tolerance of the diabetic heart. Mol. Cell. Biochem. 1997, 176, 191-198.
15. Labieniec, M.; Przygodzki, T.; Carsky, J.; Malinska, D.; Rysz, J.; Watala, C. Effects of resorcylidene aminoguanidine (RAG) on selected parameters of isolated rat liver mitochondria. Chem. Biol. Interact. 2009, 179, 280-287.
16. Watala, C.; Dobaczewski, M.; Kazmierczak, P.; Gebicki, J.; Nocun, M.; Zitnanova, I.; Ulicna, O.; Durackova, Z.; Waczulikova, I.; Carsky, J.; Chlopicki, S. Resorcylidene aminoguanidine induces antithrombotic action that is not dependent on its antiglycation activity. Vascul. Pharmacol. 2009, 51, 275-283.
17. Gnaiger, E. Capacity of oxidative phosphorylation in human skeletal muscle: New perspectives of mitochondrial physiology. Int. J. Biochem. Cell Biol. 2009, 41, 1837-1845.